53

Mangalam Drugs and Organics LtdBOM 532637 Stock Report

Last reporting period 31 Mar, 2024

Updated 05 Nov, 2024

Last price

Market cap $B

0.006

Micro

Exchange

XBOM - Bombay Stock Exchange

View Section: Price ratios

Mangalam Drugs Statements

53

Data from Mangalam Drugs`s earning releases including common size income statement and balance sheet.

Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.

Key Information:

Report currency:

INR - Indian rupee

Last reporting period:

31 Mar, 2024

Next reporting period:

27 Sep, 2024

Report frequency:

Semi-annual

Earnings release date:

Expected release date:

08 Nov, 2024

Mangalam Drugs Income Statement


Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

B

M

INR (except Earnings per share)

Financial

Revenue


Cost of sales


Gross profit


Research and development


Selling, general and administrative


Total operating expenses


Operating income


Interest expense


Other income


Income before tax


Provision for income taxes


Net income


Diluted earnings per share


Shares outstanding after dilution


2024-03-31
%

1 995.61

18.1 %

100

1 279.22

64.1

716.39

36.6 %

35.9

0

200.78

10.1

604.68

-0.7 %

30.3

111.71

232.1 %

5.6

-72.603

-3.6

0.595

0.03

39.704

126.4 %

2

-0.576

-0.03

40.28

130.7 %

2

2.54

15.946

2023-09-30
%

1 690.24

9.4 %

100

1 165.9

62.2

524.34

35 %

37.8

0

189.94

12.4

608.9

61.3 %

39.7

-84.564

-880.8 %

-1.9

-66.567

-4

0.695

0.06

-150.44

-192.2 %

-5.8

-19.439

-1.5

-131

-231.2 %

-4.4

-8.276

15.821

2023-03-31
%

1 544.37

-29.1 %

100

1 156.05

84.9

388.32

-44.7 %

15.1

0

157.15

6.9

377.49

-33.5 %

17.9

10.831

-92 %

-2.8

-66.54

-3.8

4.223

0.3

-51.486

-170 %

-6.2

-11.832

-1.4

-39.554

-175.6 %

-4.8

-2.508

15.794

2022-09-30
%

2 178.2

-6.1 %

100

1 475.9

68

702.3

-13.4 %

32

0

189

8.8

567.8

7.7 %

26.8

134.6

-52.6 %

5.2

-61

-2.4

0.1

0

73.6

-47.2 %

2.9

21.3

0.8

52.3

-51.2 %

2.1

3.33

15.7

2022-03-31
%

2 320.9

6 %

100

1 509.6

60.8

811.3

27.9 %

39.2

0

203.3

8.4

527.2

-0.6 %

21.3

284.1

173.2 %

17.9

-52.2

-1.8

-92.6

-12.5

139.3

0.9 %

3.6

32.2

-1.2

107.1

19.7 %

4.8

6.77

15.8

2021-09-30
%

2 189.8

22 %

100

1 555.5

70.3

634.3

2.9 %

29.7

0

169.2

8

530.3

19.3 %

27.6

104

-39.6 %

2.1

-59.4

-2.6

93.4

7.7

138

-13.9 %

7.3

48.5

3.3

89.5

4.3 %

4

5.65

15.8

2021-03-31
%

1 794.8

-10.6 %

100

1 178.2

67.7

616.6

-7.6 %

32.3

0

158.8

9.3

444.4

11.7 %

24.6

172.1

-36.1 %

7.6

-45.7

-2.4

33.8

2.3

160.3

-31.8 %

7.5

74.5

5.2

85.8

-55.8 %

2.4

5.43

15.8

2020-09-30
%

2 006.7

33.8 %

100

1 339.7

62.8

667

48.6 %

37.2

0

140

7.3

397.8

7.8 %

21.4

269.2

238.2 %

15.8

-47.6

-2.7

13.3

0.7

234.9

477.1 %

13.9

41.1

2.4

193.9

189.4 %

11.4

12.24

15.8

2020-03-31
%

1 500.3

13.4 %

100

1 051.7

72.2

448.8

6.5 %

27.8

0

134.1

8

369

6.6 %

22

79.6

5.9 %

5.7

-50

-2.8

11.1

0.5

40.7

86.7 %

3.5

-26.4

-2.3

67

332.3 %

5.7

4.24

15.85

2019-09-30
%

1 323.1

100

901.8

68.7

421.3

31.3

0

126.4

9.8

346.3

25.6

75.2

5.7

-54

-4.09

0.7

0.04

21.8

1.7

6.3

0.5

15.5

1.2

0.98

15.75

View Section: Balance Sheet